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Conclusion 
We have attempted to provide the practi-
tioner a foundation upon which indication 
for fluid therapy and proper selection of 
fluid may be considered when confronted 
with the clinical case. Simplicity in ap-
proach and efficient use of the practi-
tioner's time can be maintained if initial 
time is spent preparing formulations and 
equipment. The addition of a regimen of 
supportive fluid therapy to one's armament 
of therapeutic measures will add a very 
professional and rewarding dimension to 
the rural practice of bovine medicine. 
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Transplacental Passage of Drugs and Other 
Exogenous Compounds: A Review-Part IT 
by Gary A. Eckhofl,* D.V.M., M.S. 
METABOLISM OF DRUGS BY 
THE PLACENTA 
In addition to and in conjunction with 
its transport functions, the placenta posess-
es metabolic activity consisting of many 
enzyme systems which function in the bio-
synthesis, degradation, and biotransforma-
tion of numerous endogenous compounds. 
Claude Bernard was the first to discover 
glycogen in the placenta57• The role of 
placental glycogenolysis in maintaining 
early fetal glucose stores has also been 
elucidated54• In 1965 Morl discovered pro-
tein biosynthesis in the placenta38. This 
study utilized rabbits and involved pla-
cental S3:! incorporation into protein. 
Numerous active enzyme systems exist 
which function in the biosynthesis and de-
gradation of steroids. It was also discov-
• Dr. Eckhoff is an instructw of Veterin'ary Physio-
logy 'and Pharmacology, Iowa State University. 
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ered that conjugation of steroids markedly 
decreased their placental transfer26,l1. 
Thus there are extensive enzymatic capa-
bilities in the placenta for endogenous 
compounds. It would be interesting to 
speculate on the effects of drugs on these 
metabolic activities of the placenta. This 
is an area with very little investigative 
effort and resultant alteration in placental 
function could be of considerable impor-
tance to fetal physiology. 
Only within the last five years has in-
vestigative effort revealed the ability of the 
placenta to function in the biotransforma-
tion of drugs and other foreign com-
pounds. Consideration of molecular change 
of pharmacologic agents given to the 
pregnant female and assayed in the fetus 
have led workers toward investigate efforts 
in this area. As noted above, pharma-
cologically administered steroids to the 
mother are generally considered to pass 
through the placenta only in a nonmetabo-
lized state26. It is thus essential to under-
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stand how placental biotransfonnation of 
other drugs may affect their transplacental 
passage. It is also of interest to note that 
the varied drug metabolizing capabilities 
of placental tissue once again suggests a 
regulatory role of the placenta. This con-
text would infer more of a physiological 
barrier than an anatomical barrier. There 
can be no doubt that placental biotransfor-
mation influences the fonn and quantity 
in which certain foreign agents ultimately 
reach the fetal compartment. 
Preliminary evidence indicates that pla-
cental drug metabolism resembles that as-
sociated with the very familiar hepatic 
microsomal cytochrome P-450 drug metab-
olism system. The placenta, after the 
twelfth week of gestation, contains the 
pigment P-450, numerous mitochondria 
-and microsomes, and significant quanti-
ties of smooth endoplasmic reticulum in 
the trophoblastic cells22,35,5o. In vitro me-
tabolism of certain drugs also occurs with 
placental microsomal fractions and homo-
genates21• For instance, pentobarbital and 
amphetamine metabolism and hydroxyla-
tion and demethylation of polycyclic hy-
drocarbons has been demonstrated with 
rat and human placentas52,56. As in the 
case for hepatic microsomal drug metabo-
lism, these placental enzyme systems can 
be induced under certain circumstances. 
Smoking mothers have more ability for 
placental metabolism of certain agents56. 
Chlordane pretreatment also induces the 
metabolism of certain substrates such as 
hexobarbitaP2. Phenobarbital, which is a 
very familiar inducing agent in hepatic 
microsomal drug biotransformation, does 
not appear to induce the analogous sys-
tems in the placenta12,46. 
It is thus quite evident that the placenta 
does have the ability to metabolically alter 
drugs and other foreign compounds. How 
these systems effect drug transport across 
the placenta must await further investiga-
tion. Knowledge thus gained should aid 
not only in helping to understand how 
drugs are transported across the placenta, 
but also how certain drugs produce toxic 
effects on the fetus and how drugs may 
someday be employed for their therapeutic 
effects in the fetus. 
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FACTORS WHICH GOVERN THE 
DIFFUSION OF DRUGS ACROSS 
THE PLACENTA 
Before proceeding to factors which gov-
ern the diffusion of drugs across the pla-
centa, it should be pointed out that pla-
cental transfer of endogenous and some 
exogenous compounds is a two-way street. 
Although transfer to the fetus of endogen-
ous agents is important, the equally vital 
passage from fetal to maternal compart-
ments does exist. For instance, an active 
pump is known to exist which functions 
in transferring sodium from fetal to ma-
ternal blood streams3 • Although we are 
most concerned with maternal-to-fetal pas-
sage of drugs, fetal-to-maternal passage 
exists as well. As noted above, most drugs 
pass across the placenta via simple diffu-
sion and, therefore, a dynamiC equilibrium 
occurs across the placental membrane 
which eventually reaches a steady state 
condition. In many cases in the labora-
tory it is the fetal-to-maternal passage that 
is studied in order to gain evidence of pla-
cental passage. There are also isolated ex-
amples of preferential placental transfer 
from fetal to maternal circulations. Tri-
amterene, a diuretic, was transferred much 
more rapidly from the fetus than to the 
fetusll3 • It was postulated that possibly 
an active transfer process exists for this 
purine-like compound. 
Since most substances foreign to the 
body traverse the placenta via simple dif-
fusion, it is pertinent that factors which 
determine the rate of this transfer be dis-
cussed. Almost all substances cross the 
placenta, and what becomes important, 
therefore, is the rate of their passage to 
the fetus. 
The law which encompasses most of the 
factors which govern placental drug trans-
fer is Fick's Law8,o,40.41.44.53. The rate of 
diffusion is a function of the surface area 
available for transfer, the concentration 
gradient between maternal and fetal blood, 
the thickness of the membrane, and the 
diffusion constant of the drug, which 
takes into account its lipid solubility, de-
gree of ionization, molecular weight, and 
spatial configuration, The following for-
mula bears these relationships out: 
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A(Cm - Ct) 
rate of diffusion = K X 
K = diffusion constant 
A = surface area 
X = membrane thickness 
(Cm-Cr) = concentration difference be-
tween maternal and fatal 
blood 
Of the basic mechanisms of placental 
transfer discussed above, only simple dif-
fusion follows Fick's Law. It does not take 
into account the effects of maternal and 
fetal blood flow, solubility of the drug in 
fetal blood compared to maternal blood, 
and the intervillous space-fetal blood 
concentration gradient40. Solubility dif-
ferences are of particular interest when 
considering the uptake of anesthetics40. 
Blood flow is very important with highly 
fat soluble poorly ionized agents which 
penetrate the placenta with ease41. The 
rate of placenta passage in this case is 
largely determined by the volume of blood 
perfusing the placenta. Changes in blood 
flow resulting from uterine contractions, 
cord compression, position of the mother 
or any insult on blood flow to and from the 
placenta can thus affect placental drug 
transfer. 
The placenta can be thought of as a 
lipoid membrane or barrier when one 
discusses placental permeabilitYO·39.40,41. 
Highly ionized acids and bases traverse 
the placenta slowly and changes in pH 
which increase the concentration of the 
undissociated form favors the passage of 
these drugs. One would expect poor fetal 
penetration with drugs of low lipid solu-
bility. The ideal situation for rapid pass-
age is low dissociation at physiological pH 
and high lipid solubility. Thiopental and 
antipyrine are two such drugs which pene-
trate the placenta very rapidly and achieve 
equilibrium with the fetus within 1 to 2 
minutes31•32. On the other hand tubocura-
rine and succinylcholine, two drugs with a 
great deal of dissociation at body pH and 
hie-hlv lipid insoluble, traverse the pla-
cental membrane ,at an extremely slow 
rateS•3D• 
The few studies that have been done 
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on placental drug transfer strikingly re-
semble the transfer of materials across the 
blood-brain barrier or gastrointestinal 
epithelium6• However, quantitative studies 
are still too few to provide a sound basis 
for the placenta as a lipoid membrane. 
Predictions regarding the rate of trans-
placental passage of drugs must await 
further investigation. 
The lipoid theory would make it un-
likely that an analgesic could be developed 
for maternal pain and not cross the pla-
centa, since an agent that would cross 
the blood-brain barrier would also cross 
the placenta. 
As noted in the formula above, the rate 
of placental drug transfer is partially de-
pendent on the concentration gradient be-
tween fetal and maternal blood. It appears 
that a high concentration gradient can 
over-ride the effects of lipid solubility and 
ionization. This seems to be the case for 
curare and succinylcholine26.4T • 
Molecular size of the drug also deter-
mines its diffusibility. Drugs with a mo-
lecular weight of less than 600 diffuse 
across easily, but with increasing size the 
factor of lipid solubility becomes progres-
sively more important4o. A molecular 
weight of 1000 seems to be the point at 
which compounds become nearly impass-
ible4°. If the placental membrane does in-
deed fit the widely held classical concept 
that the plasma membranes are composed 
of fat-like layers interspersed with pores, 
drugs with molecular weight under 100 
could apparently pass through these pores 
bypassing the lipid region32. Larger drugs 
must pass through this region. 
Surface area and thickness of the pla-
cental membrane also have a theoretical 
bearing on the rate of transplacental dif-
fusibility of drugs. Theoretical because 
this area is virtually unstudied in the light 
of drug passage. The surface area of the 
placenta increases and the villous mem-
brane becomes thinner as gestation pro-
gresses40• These processes should tend to 
favor the transfer of pharmacological 
agents across the placenta. 
To conclude the discussion of factors 
which determine the rate of transplacental 
drug transfer it can be said that this trans-
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fer rate is governed chiefly by the lipid 
solubility of the unionized drug molecule 
with other factors, such as molecular size, 
blood flows, concentration gradients, and 
surface area and membrane thickness, us-
ually of secondary importance. 
Summary 
Various aspects of transplacental pas-
sage of pharmacological agents have been 
discussed and reviewed. Essentially all 
drugs can traverse the placenta but there 
are notable differences in the rate of 
transfer. The scarcity of quantitative 
data does not allow predictions to be made 
concerning the specific rate of transfer of 
a new drug. The foregoing discussion of 
placental pharmacology serves to illustrate 
the fragmentary knowledge on this subject 
and thus emphasizes the need for future 
investigations before this area of pharma-
cology is fully understood. 
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Annual Milk Production 
Daily per capita availability 
of milk 
Per capita income per year 
550 million 
250 million 
25 million tons 
140 mt 
$78 
Statistics can be misleading and these 
are not 100% accurate, but even allOwing 
for such limitations, it is clear that: 
a. There is scarcely half enough milk 
to meet the recommended minimum 
requirement of 250 rnl.per person 
per day. 
• Mr. Woodle is a third year student in the College 
of Veterinary Medicine, Iowa State University. 
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b. The income of millions of India's 
people are below the subsistence 
level. 
Background 
These are two basic facts of present day 
India. It was not always so. Two hundred 
years ago India's population was probably 
not more that 20% of its present level. 
Apart from periodic and regional famines, 
there was probably sufficient food for 
everyone. Cattle have always been one of 
India's great assets, providing draft power, 
transport, fuel, fertilizer and milk. It is 
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